Company: RCUS
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0001724521-25-000040
Chunk: 69

Company: Arcus Biosciences, Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 16
Chunk 69
---
. Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

NameTitleDate/s/ Terry RosenChief Executive Officer and DirectorFebruary 25, 2025Terry Rosen, Ph.D.(Principal Executive Officer)/s/ Robert C. Goeltz IIChief Financial OfficerFebruary 25, 2025Robert C. Goeltz II(Principal Financial Officer)/s/ Alexander AzoyChief Accounting OfficerFebruary 25, 2025Alexander Azoy(Principal Accounting Officer)/s/ Dietmar BergerDirectorFebruary 25, 2025Dietmar Berger, M.D., Ph.D./s/ Kathryn FalbergDirectorFebruary 25, 2025Kathryn Falberg/s/ Linda HigginsDirectorFebruary 25, 2025Linda Higgins, Ph.D./s/ Yasunori KanekoDirectorFebruary 25, 2025Yasunori Kaneko, M.D./s/ David LaceyDirectorFebruary 25, 2025David Lacey, M.D./s/ Nicole LambertDirectorFebruary 25, 2025Nicole Lambert/s/ Patrick MachadoDirectorFebruary 25, 2025Patrick Machado, J.D./s/ Johanna MercierDirectorFebruary 25, 2025Johanna Mercier/s/ Andrew PerlmanDirectorFebruary 25, 2025Andrew Perlman, M.D., Ph.D./s/ Antoni RibasDirectorFebruary 25, 2025Antoni Ribas, M.D., Ph.D.

115